Buckingham Strategic Wealth’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,664
Closed -$472K 496
2020
Q1
$472K Buy
2,664
+52
+2% +$9.79K 0.05% 259
2019
Q4
$499K Sell
2,612
-300
-10% -$54.1K 0.05% 248
2019
Q3
$490K Sell
2,912
-228
-7% -$37.1K 0.05% 234
2019
Q2
$526K Sell
3,140
-319
-9% -$44.2K 0.06% 239
2019
Q1
$506K Buy
3,459
+924
+36% +$134K 0.06% 222
2018
Q4
$339K Sell
2,535
-282
-10% -$46.2K 0.05% 247
2018
Q3
$537K Buy
+2,817
New +$518K 0.08% 182
2017
Q4
Sell
-1,031
Closed -$211K 330
2017
Q3
$211K Buy
1,031
+67
+7% +$15.6K 0.05% 271
2017
Q2
$234K Buy
964
+24
+3% +$5.64K 0.06% 256
2017
Q1
$225K Buy
+940
New +$219K 0.07% 225

Other funds holding AGN

Buckingham Strategic Wealth's AGN Position: Q2 2020 in Review

Buckingham Strategic Wealth sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,664 shares — an estimated $472K sold.

Buckingham Strategic Wealth first reported a position in AGN in Q1 2017 and held it in 10 quarters. The position peaked at $537K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Buckingham Strategic Wealth reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Buckingham Strategic Wealth sold 2,664 Allergan plc shares in Q2 2020, an estimated $472K.
  • Buckingham Strategic Wealth first reported a position in Allergan plc in Q1 2017 and held it in 10 quarters.
  • Buckingham Strategic Wealth's Allergan plc position peaked at $537K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Buckingham Strategic Wealth's 13F filing for Q2 2020, filed 3 Aug 2020.